-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RQ63NThVWE5szJjQECu1fnH6qpb7e2n8RscPQ5vSIui0vzq7G2QJVkA9JW8w0cot Kvekxq31rm/1Z9u2Iz70sg== 0000950133-04-000402.txt : 20040213 0000950133-04-000402.hdr.sgml : 20040213 20040212194404 ACCESSION NUMBER: 0000950133-04-000402 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040213 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MARSHALL EDWARDS INC CENTRAL INDEX KEY: 0001262104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510407811 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-79594 FILM NUMBER: 04593899 BUSINESS ADDRESS: STREET 1: 140 WICKS RD. CITY: NORTH RYDE STATE: C3 ZIP: NSW 2113 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: NOVOGEN LTD CENTRAL INDEX KEY: 0001075880 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 140 WICKS RD STREET 2: NORTH RYDE CITY: NEW SOUTH WALES 2113 STATE: C3 ZIP: 2113 BUSINESS PHONE: 01161298780088 MAIL ADDRESS: STREET 1: 107 NORTH RYDE CITY: SYDNEY STATE: C3 ZIP: 1670 SC 13G 1 w94184sc13g.htm SC 13G sc13g
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No.   *)1

Marshall Edwards, Inc.

(Name of Issuer)

Common Stock, par value $0.00000002 per share

(Title of Class of Securities)

572322 30 3

(CUSIP Number)

December 31, 2003

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     
o
  Rule 13d-1(b)
o
  Rule 13d-1(c)
ý
  Rule 13d-1(d)

__________________________

     1      The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

     
CUSIP No. 572322 30 3

13G
Page 2 of 2
             
1.   NAME OF REPORTING PERSON        
  I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)        
   
Novogen Limited		        
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*    
    (a)
o
  
Not Applicable (b)
o
  
3.   SEC USE ONLY        
 
4.   CITIZENSHIP OR PLACE OF ORGANIZATION        
 
  Australia        
         
    5.   SOLE VOTING POWER

49,500,000 shares of Common Stock
NUMBER OF SHARES  
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON		   6.   SHARED VOTING POWER

0 shares of Common Stock
WITH  
  7.   SOLE DISPOSITIVE POWER

49,500,000 shares of Common Stock
   
    8.   SHARED DISPOSITIVE POWER

0 shares of Common Stock
9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

49,500,000 shares of Common Stock		    
10.   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

Not applicable
o
11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

86.9%		    
12.   TYPE OF REPORTING PERSON*

CO		    

 

 

     
  CUSIP No.   572322 30 3 13 G   Page 3 of 3
         
Item 1.
  (a)   Name of Issuer:
 
        
      Marshall Edwards, Inc. (the “Company”)
 
        
  (b)   Address of Issuer’s Principal Executive Offices:
 
        
      40 Wicks Road
      North Ryde, New South Wales 2113
      Australia
 
        
Item 2.
  (a)   Name of Person Filing:
 
        
      Novogen Limited
 
        
  (b)   Address of Principal Business Office or, if None, Residence:
 
        
      140 Wicks Road, North Ryde
      New South Wales 2113
      Australia
 
        
  (c)   Citizenship:
 
        
      Australia
 
        
  (d)   Title of Class of Securities:
 
        
      Common Stock, par value $0.00000002 per share (the “Common Stock”)
 
        
  (e)   CUSIP Number:
 
        
      572322 30 3

Item 3. If this Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check whether the Person Filing is:

             
  (a)   o   Broker or dealer registered under Section 15 of the Exchange Act;
 
            
  (b)   o   Bank as defined in Section 3(a) (6) of the Exchange Act;
 
            
  (c)   o   Insurance company as defined in Section 3(a) (19) of the Exchange Act;
 
            
  (d)   o   Investment company registered under Section 8 of the Investment Company Act;
 
            
  (e)   o   An investment adviser in accordance with Rule 13-d-1(b) (1) (ii) (E);
 
            
  (f)   o   An Employee benefit plan or endowment fund in accordance with Rule 13-d-1(b) (1) (ii) (F);

 

 

     
  CUSIP No.   572322 30 3 13 G   Page 4 of 4
             
  (g)   o   A parent holding company or control person in accordance with Rule 13-d-1(b) (1) (ii) (G);
 
            
  (h)   o   A Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
 
            
  (i)   o   A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
 
            
  (j)   o   Group, in accordance with Rule 13-d-1(b) (1) (ii) (J)
 
            
  Not applicable.
     
Item 4.
  Ownership.
             
  (a)   Amount beneficially owned:
 
            
      49,500,000 shares of Common Stock
 
            
  (b)   Percent of class:
 
            
      86.9%
 
            
  (c)   Number of shares as to which the person has:
         
  (i)   Sole power to vote or to direct the vote:
 
        
      49,500,000 shares of Common Stock
 
        
  (ii)   Shared power to vote or to direct the vote:
 
        
      0 shares of Common Stock
 
        
  (iii)   Sole power to dispose or to direct the disposition of:
 
        
      49,500,000 shares of Common Stock
 
        
  (iv)   Shared power to dispose or to direct the disposition of:
 
        
      0 shares of Common Stock

Item 5. Ownership of Five Percent or Less of a Class.

     If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.

     Not applicable.

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     Not applicable.

 

 

     
  CUSIP No.   572322 30 3 13 G   Page 5 of 5

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

     Not applicable.

Item 8. Identification and Classification of Members of the Group.

     Not applicable.

Item 9. Notice of Dissolution of Group.

     Not applicable.

Item 10. Certifications.

     Not applicable.

[The remainder of this page intentionally left blank.]

 

 

     
  CUSIP No.   572322 30 3 13 G   Page 6 of 6

SIGNATURE

     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 9, 2004

Novogen Limited

By: /s/ Christopher Naughton
        Name: Christopher Naughton
        Title: President and CEO

 

-----END PRIVACY-ENHANCED MESSAGE-----